Neoadjuvant semaglutide showed no benefit in weight loss, diabetes remission or safety in a cohort of patients who underwent metabolic and bariatric surgery, according to study results published ...

Women and older adults using semaglutide, a popular anti-obesity medication, may face a heightened risk of muscle loss. A recent study suggests that women and older adults who use the weight-loss drug ...

After inking a related patent settlement last year, Viatris has cleared another obstacle in its quest to launch generic versions of Novo Nordisk’s lucrative semaglutide drugs for diabetes and ...

What happens when you stop taking Ozempic®? There’s no one-size-fits-all answer to this question. When you stop taking Ozempic for weight loss or type 2 diabetes management, you’ll eventually ...

Dr Reddy's Laboratories plans to launch a cheaper copycat version of Novo Nordisk's blockbuster weight-loss drug Wegovy in 87 countries next year, the Indian drugmaker's CEO, Erez Israeli, said on ...

India’s Dr Reddy’s Laboratories Ltd. is gearing up to launch a generic version of semaglutide — the active ingredient in Novo Nordisk A/S’s blockbuster weight-loss drug Wegovy — next year, joining ...

Additionally, losing more lean mass was tied to less of an HbA1c reduction in the semaglutide group. Increasing protein intake may help preserve muscle mass for adults with obesity using semaglutide.

Low doses of the injectable weight-loss medication semaglutide may improve symptoms of a hard-to-treat type of heart failure. This effect happened through direct action on the heart muscle and ...

Learn about safely stopping Wegovy (semaglutide), what effects it may have on your body, and ways to keep the weight off after stopping treatment.

Compared with other antidiabetic drugs, semaglutide is associated with a lower risk for Alzheimer disease-related dementia in patients with type 2 diabetes.